reports
Form 8.3 - Apex Fundrock Limited : Re Tyman plc
Apex Fundrock Limited (MISL) Form 8.3 - Apex Fundrock Limited : Re Tyman plc 03-May-2024 / 12:02 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Chelverton Asset Management (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), s...
10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ ...
10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series Ahead Of Cinco De Mayo, 10 Barrel’s Award-Winning Brew Team Introduces Pub Cerveza, A Traditional Mexican Style Lager BEND, Ore., May 03, 2024 (GLOBE NEWSWIRE) -- ("10 Barrel Brewing Co." or "10 Barrel"), a Pacific Northwestern pioneer in craft brewing, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), unveils its latest creation: Pub Cerveza. Building upon the legacy of the ‘Cheap Fun.’ family, which includes and , Pub Cerveza brings south-of-the-border spirit to the party in a smooth, crusha...
Storaktionærmeddelelse
Storaktionærmeddelelse Selskabsmeddelelse nr. 24-2023/243. maj 2024 Storaktionærmeddelelse InterMail A/S oplyser i medfør af § 30 i lov om kapitalmarkeder, at Maria Madsen-Mygdal har givet meddelelse om, at Maria Madsen-Mygdal har afhændet alle sine aktier i InterMail A/S og nu ejer 0% af aktiekapitalen og stemmerettighederne i InterMail A/S. Venlig hilsen InterMail A/S Yderligere oplysninger: John Dueholm, BestyrelsesformandTelefon: 31 24 49 31E-mail: InterMail er et datadrevet kommunikationshus, som rådgiver kunder i at skabe leads, salg samt øge kundeloyaliteten.Vi arbejder samme...
Uniti Group Inc. Reports First Quarter 2024 Results
Uniti Group Inc. Reports First Quarter 2024 Results Announced Merger with Windstream Creates Premier Insurgent Fiber Provider Updates 2024 Outlook Net Income of $41.3 Million for the First QuarterNet Income of $0.16 Per Diluted Common Share for the First QuarterAFFO Per Diluted Common Share of $0.32 for the First Quarter LITTLE ROCK, Ark., May 03, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq: UNIT) today announced its results for the first quarter 2024. “Uniti is off to a solid start in 2024. Our core recurring strategic fiber business grew 4% in the fi...
TransAlta Reports First Quarter 2024 Results
TransAlta Reports First Quarter 2024 Results CALGARY, Alberta, May 03, 2024 (GLOBE NEWSWIRE) -- TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) today reported its financial results for the first quarter ended March 31, 2024, demonstrating strong operational and financial performance and reaffirming its 2024 outlook. First Quarter 2024 Financial Highlights TransAlta’s first quarter results exceeded our expectations given the anticipated decline in Alberta spot power prices to $99 per MWh in 2024, as compared to elevated spot power prices of $142 per MWh in 20...
Notification of managers’ transactions
Ørsted A/S (Orsted) Notification of managers’ transactions 03-May-2024 / 12:57 CET/CEST 3.5.2024 12:57:18 CEST | Ørsted A/S | Managers' Transactions Ørsted A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in Ørsted A/S made by persons discharging managerial responsibilities in Ørsted A/S and/or persons closely associated with them. See the transactions of Chair of Ørsted’s Board of Directors Lene Skole in the attached PDF documents. For further information, please contact: Global Media RelationsCarst...
Shenandoah Telecommunications Company Reports First Quarter 2024 Resul...
Shenandoah Telecommunications Company Reports First Quarter 2024 Results EDINBURG, Va., May 03, 2024 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced first quarter 2024 financial and operating results. Tower segment’s financial results will be presented as discontinued operations in the Company’s Consolidated Financial Statements. Under the new organizational and reporting structure, the Company has one reportable segment in continuing operations. First Quarter 2024 Highlights Glo Fiber Markets added approximate...
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby ...
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced that Bobby Gaspar, M.D., Ph.D., co-founder and chief executive officer, has been to the inaugural 2024 TIME100 Health, an annual list recognizing the impact, innovation, and achievement of the world’s most influential individuals in health this yea...
GH Research Reports First Quarter 2024 Financial Results and Provides ...
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1 2025Phase 2a clinical trial of GH001 in postpartum depression on track for expected completion in Q3 2024Cash, cash equivalents, other financial assets and marketable securities of $214.0 million expected to provide cash runway into 2026 DUBLIN, Ireland, May 03, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasda...
Uniti to Merge with Windstream Creating Premier Insurgent Fiber Provid...
Uniti to Merge with Windstream Creating Premier Insurgent Fiber Provider Scaled Platform and Differentiated Focus on Tier II and III Markets De-levered Balance Sheet and Cash Flow Generation to Support Growth Additional Value Creation Opportunities Include up to $125 Million of Targeted Annual Opex and Capex Synergies and Enhanced Strategic Optionality LITTLE ROCK, Ark., May 03, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it has entered into a definitive agreement to merge with Windstream Holdings II, LLC (“Windstream”). Under the terms of th...
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million, representing growth of at least 20% compared to full year 2023 LOWELL, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of...
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4...
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) RESEARCH TRIANGLE PARK, N.C., May 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees stock options to purchase an aggregate of 79,575 shares, and restricted stock units (RSUs) covering an aggregate of 42,400 shares, of BioCryst common stock. The options and RSUs were granted as of April 30, 2024, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
Plug Signs MOU with Allied Green Ammonia for 3GW of Electrolyzer Suppl...
Plug Signs MOU with Allied Green Ammonia for 3GW of Electrolyzer Supply at World-Class Green Ammonia Production Facility LATHAM, N.Y., May 03, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, announced the signing of a memorandum of understanding (MOU) with Allied Green Ammonia (AGA), an Australian Company focused on green ammonia production, to supply up to 3 gigawatts (GW) of Plug electrolyzer capacity for AGA’s upcoming hydrogen to ammonia facility proposed for the Northern Territory of Australi...
DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastat...
FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC test in patients with high-risk cutaneous squamous cell carcinoma (SCC) tumors located on the head and neck (H&N) will be shared at the 56th American College of Mohs Surgery (ACMS) Annual Meeting, being held May 2-5 in Phoenix. “Mohs surgery is commonly used to remove high-risk SCC tumors located on a patient’s head or neck and is the best method to ensure complete...
ECARX Releases Multiple Intelligent Driving Features for Skyland Pro
ECARX Releases Multiple Intelligent Driving Features for Skyland Pro SHANGHAI, China, May 03, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, today announced the launch of multiple intelligent driving and safety features for its Skyland Pro computing platform, which significantly enhance the intelligent driving experience. The new features were previewed during ECARX’s second Tech Day, which was held in Hangzhou on March 20, 2024, and were released for the first time in the recent version 1.4.0 update for th...
Balchem Corporation Reports First Quarter 2024 Financial Results
Balchem Corporation Reports First Quarter 2024 Financial Results MONTVALE, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal first quarter ended March 31, 2024. The Company reported quarterly net sales of $239.7 million, quarterly net earnings of $29.0 million, adjusted EBITDA(a) of $60.9 million, and free cash flow(a) of $26.8 million. Ted Harris, Chairman, President and CEO of Balchem said, "The first quarter was a very good start to the year for Balchem. We delivered record net sales, adjusted EBITDA, and...
Telesat First Quarter 2024 Earnings Conference Call
Telesat First Quarter 2024 Earnings Conference Call OTTAWA, May 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative satellite operators, has scheduled a conference call on Friday, May 10, 2024 at 10:30 a.m. ET to discuss its financial results for the three month period ended March 31, 2024. The call will be hosted by Daniel S. Goldberg, President and Chief Executive Officer, and Andrew Browne, Chief Financial Officer, of Telesat. Prior to the commencement of the call, Telesat will post a news release containing its financial results on i...
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Int...
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine – Trial did not meet primary endpoint – IRVINE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions, today announced that the preliminary top-line results from its planned interim analysis of the Phase 2 trial with ABP-450 in the preve...
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Develop...
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics FLORHAM PARK, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced it will host a Research and Development (R&D) Day to discuss the current unmet medical needs and the potential of Plinabulin as a novel immunochemotherapeutic in drug combinations and updates for SEED Therapeutics on Wednesday, May 15th, 2024 at...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.